专题:Health Systems, Economic Evaluations, Quality of Life

This cluster of papers focuses on the intersection of health economics and quality of life assessment, with a particular emphasis on cost-effectiveness analysis, health utility measures such as EQ-5D and SF-36, quality-adjusted life years (QALY), health technology assessment, and preference-based measures for evaluating the economic impact of healthcare interventions.
最新文献
近5年高被引文献
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 6428 FWCI1083.0895

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 5065 FWCI1491.7111

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

article Full Text OpenAlex 1106 FWCI151.1401

Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050

article Full Text OpenAlex 904 FWCI182.347

The Global Burden of Disease Study at 30 years

article Full Text OpenAlex 865 FWCI115.8483

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

article Full Text OpenAlex 843 FWCI133.4514

Economic Costs of Diabetes in the U.S. in 2022

article Full Text OpenAlex 802 FWCI160.1175

Quantifying the global burden of mental disorders and their economic value

article Full Text OpenAlex 780 FWCI122.5264

Economic impacts of overweight and obesity: current and future estimates for 161 countries

article Full Text OpenAlex 734 FWCI102.3117

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

article Full Text OpenAlex 641 FWCI73.2716